Search research articles
Contact Us
Filters
Showing results (241-250 of 259) with videos related to
Page
of 26
Sort By:
Oncotarget
|
November 3, 2016
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Polina Matre, Juliana Velez, Rodrigo Jacamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Juliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 26, 2019
Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments
M Dosanjh, A Aggarwal, D Pistenmaa, et al.
The American Journal of Surgical Pathology
|
February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases
Mariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group
Rong-Jian Lu, John A Tucker, Tatiana Zinevitch, et al.
Haematologica
|
February 16, 2015
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Marina Konopleva, Peter F Thall, Cecilia Arana Yi, et al.
Research Square
|
May 10, 2023
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
Katie H Hurrish, Yongwei Su, Shraddha Patel, et al.
Journal of Medicinal Chemistry
|
June 19, 2009
Heterobiaryl human immunodeficiency virus entry inhibitors
Rong-Jian Lu, John A Tucker, Jason Pickens, et al.
Blood
|
December 7, 2016
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
Nitin Jain, Kathryn G Roberts, Elias Jabbour, et al.
Biochemical Pharmacology
|
December 11, 2023
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro
Katie H Hurrish, Yongwei Su, Shraddha Patel, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 259) with videos related to
Sort By:
Page
of 26
Oncotarget
|
November 3, 2016
Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
Polina Matre, Juliana Velez, Rodrigo Jacamo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Juliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 26, 2019
Developing Innovative, Robust and Affordable Medical Linear Accelerators for Challenging Environments
M Dosanjh, A Aggarwal, D Pistenmaa, et al.
The American Journal of Surgical Pathology
|
February 13, 2016
Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases
Mariko Yabe, L Jeffrey Medeiros, Guilin Tang, et al.
Journal of Medicinal Chemistry
|
December 7, 2007
Design and synthesis of human immunodeficiency virus entry inhibitors: sulfonamide as an isostere for the alpha-ketoamide group
Rong-Jian Lu, John A Tucker, Tatiana Zinevitch, et al.
Haematologica
|
February 16, 2015
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia
Marina Konopleva, Peter F Thall, Cecilia Arana Yi, et al.
Research Square
|
May 10, 2023
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis
Katie H Hurrish, Yongwei Su, Shraddha Patel, et al.
Journal of Medicinal Chemistry
|
June 19, 2009
Heterobiaryl human immunodeficiency virus entry inhibitors
Rong-Jian Lu, John A Tucker, Jason Pickens, et al.
Blood
|
December 7, 2016
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults
Nitin Jain, Kathryn G Roberts, Elias Jabbour, et al.
Biochemical Pharmacology
|
December 11, 2023
Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro
Katie H Hurrish, Yongwei Su, Shraddha Patel, et al.
Page
of 26